Level 2

Hikma Pharmaceuticals director buys-in after full-year results

By Alexander Bueso

Date: Thursday 14 Mar 2019

Hikma Pharmaceuticals director buys-in after full-year results

(Sharecast News) - One of Hikma Pharmaceuticals's directors picked-up some shares in the company the day after its latest full-year numbers.
On Thursday, Dr. Pamela Kirby, a non-executive director at the non-branded generic and in-licensed pharmaceutical products maker, purchased 1,500 shares, on the market, at 1,586p apiece for a total transaction amount of £23,790.

The day before, Hikma had posted a 7% increase in full-year 2018 core revenues to $2.08bn with core operating profit up by 19% at $460m, but its sales were 1% below the average analyst forecast and profit was 2% light.

Core basic earnings per share, however, increased 31% to 137.8 cents, beating the consensus by 2% due to lower finance charges, while cash-flow from operating activities of $430m down from $443m.

Her purchase followed others by the executive chairman and vice-chairman, Said Darwazah and Mazen Darwazah, respectively, also the day before.

Analysts at Numis described the company's results as "strong" but said consensus estimates might be set for "modest downgrades".

"The shares aren't particularly cheap and conditions in US generics remain volatile and with the shares trading on 11 times's EV/EBITDA we stick with the 'hold' rating."

Top Director Buys

Hikma Pharmaceuticals (HIK)
Director name: Kirby,Pamela
Amount purchased: 1,500 @ 1,586.00p
Value: £23,790.00

4d Pharma (DDDD)
Director name: Stevenson,Alexander James
Amount purchased: 24,896 @ 91.50p
Value: £22,779.84

Haydale Graphene Industries (HAYD)
Director name: Humm,Roger James
Amount purchased: 841,432 @ 2.00p
Value: £16,828.64

Haydale Graphene Industries (HAYD)
Director name: Broadbent,Keith
Amount purchased: 500,000 @ 2.00p
Value: £10,000.00

Haydale Graphene Industries (HAYD)
Director name: Banks,David
Amount purchased: 500,000 @ 2.00p
Value: £10,000.00

Haydale Graphene Industries (HAYD)
Director name: Redman-Thomas,Laura
Amount purchased: 375,000 @ 2.00p
Value: £7,500.00

4d Pharma (DDDD)
Director name: Peyton,Duncan Joseph
Amount purchased: 6,770 @ 92.00p
Value: £6,228.40

React Group (REAT)
Director name: Joyce,Michael
Amount purchased: 2,000,000 @ 0.27p
Value: £5,340.00

React Group (REAT)
Director name: Joyce,Michael
Amount purchased: 1,000,000 @ 0.27p
Value: £2,670.00

Kcom Group (KCOM)
Director name: Bielby,Anna
Amount purchased: 217 @ 69.18p
Value: £150.12

Zotefoams (ZTF)
Director name: Stirling,David
Amount purchased: 25 @ 599.00p
Value: £149.75

Zotefoams (ZTF)
Director name: McGrath ,Gary
Amount purchased: 25 @ 599.00p
Value: £149.75



Top Director Sells

Record (REC)
Director name: Wood-Collins,James
Amount sold: 146,716 @ 28.70p
Value: £42,107.49

..

Email this article to a friend

or share it with one of these popular networks:


Top of Page